Karyopharm Therapeutics
KPTI
#10482
Rank
ยฃ31.54 M
Marketcap
ยฃ1.39
Share price
-1.06%
Change (1 day)
-67.87%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: ยฃ31.54 Million

As of September 2026 Karyopharm Therapeutics has a market cap of ยฃ31.54 Million. This makes Karyopharm Therapeutics the world's 10482th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ31.54 M-66.51%
2025ยฃ94.19 M33.63%
2024ยฃ70.49 M-9.35%
2023ยฃ77.76 M-75.56%
2022ยฃ0.31 B-11.59%
2021ยฃ0.35 B-56.95%
2020ยฃ0.83 B-12.53%
2019ยฃ0.95 B112.83%
2018ยฃ0.44 B33.98%
2017ยฃ0.33 B6.66%
2016ยฃ0.31 B-2.02%
2015ยฃ0.32 B-59.21%
2014ยฃ0.78 B91.22%
2013ยฃ0.41 B

End of Day market cap according to different sources

On Sep 21st, 2026 the market cap of Karyopharm Therapeutics was reported to be:

ยฃ31.54 Million
by Nasdaq info icon info icon
ยฃ31.54 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
ยฃ133.24 B 422,287.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ275.80 B 874,192.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ95.64 B 303,105.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ10.60 B 33,507.26%๐Ÿ‡บ๐Ÿ‡ธ USA